Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor	GLUD1 GLUD2	8.29e-06	2	58	2	GO:0016639
GeneOntologyMolecularFunction	glutamate dehydrogenase [NAD(P)+] activity	GLUD1 GLUD2	8.29e-06	2	58	2	GO:0004353
GeneOntologyMolecularFunction	glutamate dehydrogenase (NAD+) activity	GLUD1 GLUD2	8.29e-06	2	58	2	GO:0004352
GeneOntologyMolecularFunction	glutamate dehydrogenase (NADP+) activity	GLUD1 GLUD2	8.29e-06	2	58	2	GO:0004354
GeneOntologyMolecularFunction	histone H2AK119 ubiquitin ligase activity	PCGF3 PCGF5	4.96e-05	4	58	2	GO:0140862
GeneOntologyMolecularFunction	histone H2A ubiquitin ligase activity	PCGF3 PCGF5	1.23e-04	6	58	2	GO:0141053
GeneOntologyMolecularFunction	L-leucine binding	GLUD1 GLUD2	1.73e-04	7	58	2	GO:0070728
GeneOntologyMolecularFunction	ADP binding	GLUD1 GLUD2 MYO18A	3.67e-04	48	58	3	GO:0043531
GeneOntologyMolecularFunction	histone ubiquitin ligase activity	PCGF3 PCGF5	5.37e-04	12	58	2	GO:0140852
GeneOntologyMolecularFunction	carboxylic acid binding	P4HA2 ACACB NRTN GLUD1 GLUD2	6.44e-04	239	58	5	GO:0031406
GeneOntologyMolecularFunction	organic acid binding	P4HA2 ACACB NRTN GLUD1 GLUD2	8.47e-04	254	58	5	GO:0043177
GeneOntologyMolecularFunction	protein domain specific binding	WBP11 CRIM1 CASKIN1 DLG3 CARD11 RELA RIMS2 MYB ITPR1	8.83e-04	875	58	9	GO:0019904
GeneOntologyMolecularFunction	phosphate ion binding	SH2B3 RELA	9.69e-04	16	58	2	GO:0042301
GeneOntologyMolecularFunction	oxidoreductase activity, acting on the CH-NH2 group of donors	GLUD1 GLUD2	1.52e-03	20	58	2	GO:0016638
GeneOntologyMolecularFunction	NAD+ binding	GLUD1 GLUD2	1.52e-03	20	58	2	GO:0070403
GeneOntologyBiologicalProcess	tricarboxylic acid metabolic process	ACACB GLUD1 GLUD2	1.59e-05	18	57	3	GO:0072350
GeneOntologyBiologicalProcess	dosage compensation by inactivation of X chromosome	PCGF3 YTHDC1 PCGF5	2.97e-05	22	57	3	GO:0009048
GeneOntologyBiologicalProcess	sex-chromosome dosage compensation	PCGF3 YTHDC1 PCGF5	3.89e-05	24	57	3	GO:0007549
GeneOntologyBiologicalProcess	glutamate biosynthetic process	GLUD1 GLUD2	7.46e-05	5	57	2	GO:0006537
GeneOntologyBiologicalProcess	response to aluminum ion	GLUD1 GLUD2	1.12e-04	6	57	2	GO:0010044
GeneOntologyBiologicalProcess	chromatin organization	SATB1 SUPT6H SMARCA1 BAZ1B RELA PCGF3 YTHDC1 INO80D PCGF5 JMJD1C	1.53e-04	896	57	10	GO:0006325
GeneOntologyBiologicalProcess	chromatin remodeling	SATB1 SUPT6H SMARCA1 BAZ1B PCGF3 YTHDC1 INO80D PCGF5 JMJD1C	1.82e-04	741	57	9	GO:0006338
GeneOntologyBiologicalProcess	glutamate catabolic process	GLUD1 GLUD2	2.08e-04	8	57	2	GO:0006538
GeneOntologyCellularComponent	nuclear protein-containing complex	CDK13 SUPT6H POLR1C SMARCA1 CPSF1 BAZ1B RELA ASCC3 PCGF3 INO80D PCGF5 JMJD1C MYB	8.05e-05	1377	58	13	GO:0140513
Domain	ELFV_dehydrog_N	GLUD1 GLUD2	8.83e-06	2	56	2	PF02812
Domain	Glu/Leu/Phe/Val_DH_C	GLUD1 GLUD2	8.83e-06	2	56	2	IPR006096
Domain	Glu/Leu/Phe/Val_DH_dimer_dom	GLUD1 GLUD2	8.83e-06	2	56	2	IPR006097
Domain	Glu/Leu/Phe/Val_DH	GLUD1 GLUD2	8.83e-06	2	56	2	IPR006095
Domain	ELFV_dehydrog	GLUD1 GLUD2	8.83e-06	2	56	2	PF00208
Domain	ELFV_dehydrog	GLUD1 GLUD2	8.83e-06	2	56	2	SM00839
Domain	Glu/Leu/Phe/Val_DH_AS	GLUD1 GLUD2	8.83e-06	2	56	2	IPR033524
Domain	NAD_bind_Glu_DH	GLUD1 GLUD2	8.83e-06	2	56	2	IPR033922
Domain	GLFV_DEHYDROGENASE	GLUD1 GLUD2	8.83e-06	2	56	2	PS00074
Domain	RAWUL	PCGF3 PCGF5	1.84e-04	7	56	2	IPR032443
Domain	RAWUL	PCGF3 PCGF5	1.84e-04	7	56	2	PF16207
Domain	PDZ	MYO18A DLG3 CARD11 RIMS2	1.01e-03	148	56	4	SM00228
Domain	-	MYO18A DLG3 CARD11 RIMS2	1.06e-03	150	56	4	2.30.42.10
Domain	PDZ	MYO18A DLG3 CARD11 RIMS2	1.09e-03	151	56	4	PS50106
Domain	PDZ	MYO18A DLG3 CARD11 RIMS2	1.11e-03	152	56	4	IPR001478
Domain	GUANYLATE_KINASE_2	DLG3 CARD11	2.15e-03	23	56	2	PS50052
Domain	GUANYLATE_KINASE_1	DLG3 CARD11	2.15e-03	23	56	2	PS00856
Domain	Znf_RING/FYVE/PHD	RNF181 BAZ1B PCGF3 RIMS2 PCGF5 WDR59	2.45e-03	459	56	6	IPR013083
Domain	Cadherin_cytoplasmic-dom	DSC1 CDH15	2.53e-03	25	56	2	IPR000233
Domain	Cadherin_C	DSC1 CDH15	2.53e-03	25	56	2	PF01049
Domain	Catenin_binding_dom	DSC1 CDH15	3.40e-03	29	56	2	IPR027397
Domain	-	DSC1 CDH15	3.40e-03	29	56	2	4.10.900.10
Domain	-	MYO18A SMARCA1 DLG3 CARD11 ASCC3 REM2 DNAH7	6.67e-03	746	56	7	3.40.50.300
Domain	PDZ	MYO18A DLG3 RIMS2	8.72e-03	141	56	3	PF00595
Pathway	KEGG_MEDICUS_REFERENCE_BLOCKING_UBIQUITINATION_OF_H2AK119_BY_CK2	AUTS2 PCGF3 PCGF5	6.12e-06	12	44	3	M47943
Pathway	KEGG_MEDICUS_REFERENCE_TRANSCRIPTIONAL_ACTIVATION_BY_ACETYLATION_OF_H3K27	AUTS2 PCGF3 PCGF5	1.26e-05	15	44	3	M47973
Pathway	WP_TCELL_RECEPTOR_SIGNALING	SH2B3 CARD11 RELA ITPR1	1.73e-04	90	44	4	M39725
Pubmed	Human transcription factor protein interaction networks.	WBP11 IRS4 SATB1 ACACB USP9X GLI3 GLUD1 MYO18A SMARCA1 AUTS2 CPSF1 BAZ1B RELA PCGF3 INO80D PCGF5 JMJD1C MYB	9.45e-12	1429	58	18	35140242
Pubmed	Genomic organization and chromosomal localization of the mouse synexin gene.	GLUD1 GLUD2 MYB	4.39e-08	5	58	3	8053909
Pubmed	Interaction network of human early embryonic transcription factors.	SATB1 ACACB GLUD1 SMARCA1 AUTS2 BAZ1B PCGF3 PCGF5	1.23e-07	351	58	8	38297188
Pubmed	Isolation and genetic mapping of two novel members of the murine Wnt gene family, Wnt11 and Wnt12, and the mapping of Wnt5a and Wnt7a.	GLUD1 GLUD2 ITPR1	9.58e-07	12	58	3	7896292
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	MAGEB1 HECTD4 DLG3 PRAMEF11 MYB ITPR1 NGDN	2.42e-06	363	58	7	14691545
Pubmed	TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions.	WBP11 IRS4 USP9X ZC3H13 GLUD1 AUTS2 CPSF1 RELA YTHDC1 NGDN	2.69e-06	922	58	10	27609421
Pubmed	ANKRD49 inhibits etoposide-induced intrinsic apoptosis of GC-1 cells by modulating NF-κB signaling.	ANKRD49 RELA	2.73e-06	2	58	2	30798416
Pubmed	Critical role of the cysteine 323 residue in the catalytic activity of human glutamate dehydrogenase isozymes.	GLUD1 GLUD2	2.73e-06	2	58	2	15750346
Pubmed	Molecular cloning, structure and expression analysis of a full-length mouse brain glutamate dehydrogenase cDNA.	GLUD1 GLUD2	2.73e-06	2	58	2	1711373
Pubmed	Glutamate Delta-1 Receptor Regulates Inhibitory Neurotransmission in the Nucleus Accumbens Core and Anxiety-Like Behaviors.	GLUD1 GLUD2	2.73e-06	2	58	2	34173171
Pubmed	Glutamate dehydrogenase is essential to sustain neuronal oxidative energy metabolism during stimulation.	GLUD1 GLUD2	2.73e-06	2	58	2	28621566
Pubmed	GluD1 knockout mice with a pure C57BL/6N background show impaired fear memory, social interaction, and enhanced depressive-like behavior.	GLUD1 GLUD2	2.73e-06	2	58	2	32078638
Pubmed	Transcriptomic responses in mouse brain exposed to chronic excess of the neurotransmitter glutamate.	GLUD1 GLUD2	2.73e-06	2	58	2	20529287
Pubmed	Development of mice with brain-specific deletion of floxed glud1 (glutamate dehydrogenase 1) using cre recombinase driven by the nestin promoter.	GLUD1 GLUD2	2.73e-06	2	58	2	23595828
Pubmed	Determination of glutamate dehydrogenase activity and its kinetics in mouse tissues using metabolic mapping (quantitative enzyme histochemistry).	GLUD1 GLUD2	2.73e-06	2	58	2	25124006
Pubmed	Unexpected histone H3 tail-clipping activity of glutamate dehydrogenase.	GLUD1 GLUD2	2.73e-06	2	58	2	23673664
Pubmed	Interaction between glutamate dehydrogenase (GDH) and L-leucine catabolic enzymes: intersecting metabolic pathways.	GLUD1 GLUD2	2.73e-06	2	58	2	21621574
Pubmed	Lack of evidence for direct ligand-gated ion channel activity of GluD receptors.	GLUD1 GLUD2	2.73e-06	2	58	2	39052831
Pubmed	Metabolism changes during aging in the hippocampus and striatum of glud1 (glutamate dehydrogenase 1) transgenic mice.	GLUD1 GLUD2	2.73e-06	2	58	2	24442550
Pubmed	Identification of the molecular dysfunction caused by glutamate dehydrogenase S445L mutation responsible for hyperinsulinism/hyperammonemia.	GLUD1 GLUD2	2.73e-06	2	58	2	28911206
Pubmed	The Amplifying Pathway of the β-Cell Contributes to Diet-induced Obesity.	GLUD1 GLUD2	2.73e-06	2	58	2	27137930
Pubmed	GDH-Dependent Glutamate Oxidation in the Brain Dictates Peripheral Energy Substrate Distribution.	GLUD1 GLUD2	2.73e-06	2	58	2	26440896
Pubmed	Delineation of glutamate pathways and secretory responses in pancreatic islets with β-cell-specific abrogation of the glutamate dehydrogenase.	GLUD1 GLUD2	2.73e-06	2	58	2	22875990
Pubmed	Study of structure-function relationships in human glutamate dehydrogenases reveals novel molecular mechanisms for the regulation of the nerve tissue-specific (GLUD2) isoenzyme.	GLUD1 GLUD2	2.73e-06	2	58	2	12742085
Pubmed	Molecular basis of human glutamate dehydrogenase regulation under changing energy demands.	GLUD1 GLUD2	2.73e-06	2	58	2	15578726
Pubmed	Important role of Ser443 in different thermal stability of human glutamate dehydrogenase isozymes.	GLUD1 GLUD2	2.73e-06	2	58	2	15044002
Pubmed	Induction of excitatory and inhibitory presynaptic differentiation by GluD1.	GLUD1 GLUD2	2.73e-06	2	58	2	22138648
Pubmed	Glutamate Dehydrogenase Is Important for Ammonia Fixation and Amino Acid Homeostasis in Brain During Hyperammonemia.	GLUD1 GLUD2	2.73e-06	2	58	2	34220417
Pubmed	Expression of human GLUD1 and GLUD2 glutamate dehydrogenases in steroid producing tissues.	GLUD1 GLUD2	2.73e-06	2	58	2	26241911
Pubmed	Differential levels of glutamate dehydrogenase 1 (GLUD1) in Balb/c and C57BL/6 mice and the effects of overexpression of the Glud1 gene on glutamate release in striatum.	GLUD1 GLUD2	2.73e-06	2	58	2	21446915
Pubmed	Mitochondrial targeting adaptation of the hominoid-specific glutamate dehydrogenase driven by positive Darwinian selection.	GLUD1 GLUD2	2.73e-06	2	58	2	18688271
Pubmed	The complex regulation of human glud1 and glud2 glutamate dehydrogenases and its implications in nerve tissue biology.	GLUD1 GLUD2	2.73e-06	2	58	2	22658952
Pubmed	GluD1 binds GABA and controls inhibitory plasticity.	GLUD1 GLUD2	2.73e-06	2	58	2	38060673
Pubmed	Gene expression patterns in the hippocampus during the development and aging of Glud1 (Glutamate Dehydrogenase 1) transgenic and wild type mice.	GLUD1 GLUD2	2.73e-06	2	58	2	24593767
Pubmed	Increases in anterograde axoplasmic transport in neurons of the hyper-glutamatergic, glutamate dehydrogenase 1 (Glud1) transgenic mouse: Effects of glutamate receptors on transport.	GLUD1 GLUD2	2.73e-06	2	58	2	38124277
Pubmed	Potentiation of neuronal activity by tonic GluD1 current in brain slices.	GLUD1 GLUD2	2.73e-06	2	58	2	37154294
Pubmed	Deletion of glutamate dehydrogenase in beta-cells abolishes part of the insulin secretory response not required for glucose homeostasis.	GLUD1 GLUD2	2.73e-06	2	58	2	19015267
Pubmed	Deletion of glutamate dehydrogenase 1 (Glud1) in the central nervous system affects glutamate handling without altering synaptic transmission.	GLUD1 GLUD2	2.73e-06	2	58	2	22924626
Pubmed	Human GLUD1 and GLUD2 glutamate dehydrogenase localize to mitochondria and endoplasmic reticulum.	GLUD1 GLUD2	2.73e-06	2	58	2	19448744
Pubmed	Nerve tissue-specific (GLUD2) and housekeeping (GLUD1) human glutamate dehydrogenases are regulated by distinct allosteric mechanisms: implications for biologic function.	GLUD1 GLUD2	2.73e-06	2	58	2	11032875
Pubmed	Polycomb group RING finger proteins 3/5 activate transcription via an interaction with the pluripotency factor Tex10 in embryonic stem cells.	PCGF3 PCGF5	2.73e-06	2	58	2	29054931
Pubmed	Single amino acid substitution (G456A) in the vicinity of the GTP binding domain of human housekeeping glutamate dehydrogenase markedly attenuates GTP inhibition and abolishes the cooperative behavior of the enzyme.	GLUD1 GLUD2	2.73e-06	2	58	2	11950837
Pubmed	Localization of Human Glutamate Dehydrogenases Provides Insights into Their Metabolic Role and Their Involvement in Disease Processes.	GLUD1 GLUD2	2.73e-06	2	58	2	29943084
Pubmed	Glutamate dehydrogenase deficiency disrupts glutamate homeostasis in hippocampus and prefrontal cortex and impairs recognition memory.	GLUD1 GLUD2	2.73e-06	2	58	2	31898404
Pubmed	Birth and adaptive evolution of a hominoid gene that supports high neurotransmitter flux.	GLUD1 GLUD2	2.73e-06	2	58	2	15378063
Pubmed	Widening Spectrum of Cellular and Subcellular Expression of Human GLUD1 and GLUD2 Glutamate Dehydrogenases Suggests Novel Functions.	GLUD1 GLUD2	2.73e-06	2	58	2	27422263
Pubmed	NRF1 association with AUTS2-Polycomb mediates specific gene activation in the brain.	AUTS2 PCGF3 PCGF5	2.94e-06	17	58	3	34637754
Pubmed	Polymorphisms revealed by PCR with single, short-sized, arbitrary primers are reliable markers for mouse and rat gene mapping.	GLUD1 GLUD2 MYB	2.94e-06	17	58	3	1617216
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	WBP11 IRS4 ACACB CDK13 GLUD1 GLUD2 MYO18A SMARCA1 DLG3 SPAG17 RIMS2 NGDN	3.75e-06	1442	58	12	35575683
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	DSC1 SUPT6H VPS13C GLUD2 MYO18A CPSF1 BAZ1B RIMS2 ITPR1	4.16e-06	754	58	9	35906200
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	DSC1 ZC3H13 GLUD1 POLR1C MYO18A SMARCA1 CPSF1 BAZ1B ASCC3 YTHDC1 NGDN	6.30e-06	1257	58	11	36526897
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	WBP11 DSC1 SUPT6H ZC3H13 SMARCA1 BAZ1B ASCC3 NGDN	7.14e-06	605	58	8	28977666
Pubmed	Postsynaptic δ1 glutamate receptor assembles and maintains hippocampal synapses via Cbln2 and neurexin.	GLUD1 GLUD2	8.19e-06	3	58	2	29784783
Pubmed	The structure of apo human glutamate dehydrogenase details subunit communication and allostery.	GLUD1 GLUD2	8.19e-06	3	58	2	12054821
Pubmed	Trans-Synaptic Signaling through the Glutamate Receptor Delta-1 Mediates Inhibitory Synapse Formation in Cortical Pyramidal Neurons.	GLUD1 GLUD2	8.19e-06	3	58	2	31704028
Pubmed	Glutamine-Elicited Secretion of Glucagon-Like Peptide 1 Is Governed by an Activated Glutamate Dehydrogenase.	GLUD1 GLUD2	8.19e-06	3	58	2	29229616
Pubmed	Liver Glutamate Dehydrogenase Controls Whole-Body Energy Partitioning Through Amino Acid-Derived Gluconeogenesis and Ammonia Homeostasis.	GLUD1 GLUD2	8.19e-06	3	58	2	30002133
Pubmed	Glutamate delta-1 receptor regulates cocaine-induced plasticity in the nucleus accumbens.	GLUD1 GLUD2	8.19e-06	3	58	2	30315226
Pubmed	Regulation of NF-kappaB activation in T cells via association of the adapter proteins ADAP and CARMA1.	CARD11 RELA	8.19e-06	3	58	2	17478723
Pubmed	Isolation of a human brain cDNA for glutamate dehydrogenase.	GLUD1 GLUD2	8.19e-06	3	58	2	3585334
Pubmed	GOT1 regulates CD8+ effector and memory T cell generation.	GLUD1 GLUD2	8.19e-06	3	58	2	36640309
Pubmed	Screening for new inhibitors of the human Mitochondrial Pyruvate Carrier and their effects on hepatic glucose production and diabetes.	GLUD1 GLUD2	8.19e-06	3	58	2	37871770
Pubmed	Human T-cell lymphotropic virus type 1 Tax represses c-Myb-dependent transcription through activation of the NF-kappaB pathway and modulation of coactivator usage.	RELA MYB	8.19e-06	3	58	2	11585920
Pubmed	Deletion of glutamate delta-1 receptor in mouse leads to enhanced working memory and deficit in fear conditioning.	GLUD1 GLUD2	8.19e-06	3	58	2	23560106
Pubmed	Mechanism of hyperinsulinism in short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency involves activation of glutamate dehydrogenase.	GLUD1 GLUD2	8.19e-06	3	58	2	20670938
Pubmed	Identification of disulfide bond formation between MitoNEET and glutamate dehydrogenase 1.	GLUD1 GLUD2	8.19e-06	3	58	2	24295216
Pubmed	New gene functions in megakaryopoiesis and platelet formation.	SATB1 SH2B3 JMJD1C MYB	1.05e-05	81	58	4	22139419
Pubmed	Enriched expression of GluD1 in higher brain regions and its involvement in parallel fiber-interneuron synapse formation in the cerebellum.	GLUD1 GLUD2	1.64e-05	4	58	2	24872547
Pubmed	Essential role of GluD1 in dendritic spine development and GluN2B to GluN2A NMDAR subunit switch in the cortex and hippocampus reveals ability of GluN2B inhibition in correcting hyperconnectivity.	GLUD1 GLUD2	1.64e-05	4	58	2	25721396
Pubmed	The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4.	GLUD1 GLUD2	1.64e-05	4	58	2	23663782
Pubmed	Members of the nuclear factor kappa B family transactivate the murine c-myb gene.	RELA MYB	1.64e-05	4	58	2	7706314
Pubmed	GLUD1 determines murine muscle stem cell fate by controlling mitochondrial glutamate levels.	GLUD1 GLUD2	1.64e-05	4	58	2	39121856
Pubmed	A restriction fragment length polymorphism at murine Glud locus co-segregates with Rib-1, Es-10, and Tcra on chromosome 14.	GLUD1 GLUD2	1.64e-05	4	58	2	2566156
Pubmed	A genome- and phenome-wide association study to identify genetic variants influencing platelet count and volume and their pleiotropic effects.	SH2B3 JMJD1C MYB	2.54e-05	34	58	3	24026423
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	DSC1 CDK13 MYO18A CPSF1 YTHDC1 NEXN USP6NL ITPR1 NGDN	2.59e-05	949	58	9	36574265
Pubmed	Chromosomal mapping of glutamate dehydrogenase gene sequences to mouse chromosomes 7 and 14.	GLUD1 GLUD2	2.72e-05	5	58	2	2045113
Pubmed	Proximity of the CTLA-1 serine esterase and Tcr alpha loci in mouse and man.	GLUD1 GLUD2	2.72e-05	5	58	2	3182016
Pubmed	Chromosomal assignment of 11 loci in the rat by mouse-rat somatic hybrids and linkage.	GLUD1 GLUD2	2.72e-05	5	58	2	7873882
Pubmed	SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells.	GLUD1 GLUD2	2.72e-05	5	58	2	16959573
Pubmed	Combined analysis of exon splicing and genome wide polymorphism data predict schizophrenia risk loci.	ZC3H13 DLG3	2.72e-05	5	58	2	24507884
Pubmed	Macrophage-derived glutamine boosts satellite cells and muscle regeneration.	GLUD1 GLUD2	2.72e-05	5	58	2	33116312
Pubmed	Regulation of T cell function by the ubiquitin-specific protease USP9X via modulating the Carma1-Bcl10-Malt1 complex.	USP9X CARD11	2.72e-05	5	58	2	23690623
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SUPT6H VPS13C CASKIN1 HECTD4 AUTS2 RIMS2 USP6NL	2.78e-05	529	58	7	14621295
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	WBP11 SUPT6H ZC3H13 GLUD1 POLR1C MYO18A BAZ1B ASCC3 HSPA12B USP6NL ITPR1	3.01e-05	1487	58	11	33957083
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	CDK13 ZC3H13 CARD11 YTHDC1 JMJD1C NGDN	3.08e-05	361	58	6	26167880
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	CDK13 SUPT6H POLR1C BAZ1B DLG3 RELA ASCC3 YTHDC1 INO80D USP6NL NGDN	3.20e-05	1497	58	11	31527615
Pubmed	An AUTS2-Polycomb complex activates gene expression in the CNS.	AUTS2 PCGF3 PCGF5	3.56e-05	38	58	3	25519132
Pubmed	Proteomic and yeast 2-hybrid screens to identify PTEN binding partners.	USP9X GLUD1 GLUD2 MYO18A ASCC3	3.84e-05	226	58	5	37839992
Pubmed	The human glutamate dehydrogenase gene family: gene organization and structural characterization.	GLUD1 GLUD2	4.08e-05	6	58	2	8486350
Pubmed	hnRNPK Recruits PCGF3/5-PRC1 to the Xist RNA B-Repeat to Establish Polycomb-Mediated Chromosomal Silencing.	PCGF3 PCGF5	4.08e-05	6	58	2	29220657
Pubmed	Synergy between Variant PRC1 Complexes Defines Polycomb-Mediated Gene Repression.	PCGF3 PCGF5	4.08e-05	6	58	2	31029541
Pubmed	WSTF-ISWI chromatin remodeling complex targets heterochromatic replication foci.	SMARCA1 BAZ1B	4.08e-05	6	58	2	11980720
Pubmed	PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes.	AUTS2 PCGF3 PCGF5	4.49e-05	41	58	3	22325352
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	CDK13 SUPT6H ZC3H13 POLR1C CPSF1 BAZ1B YTHDC1 INO80D JMJD1C NGDN	5.04e-05	1294	58	10	30804502
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	WBP11 CDK13 SUPT6H ZC3H13 MYO18A ASCC3 YTHDC1 NGDN	5.58e-05	807	58	8	22681889
Pubmed	Essential Role for Polycomb Group Protein Pcgf6 in Embryonic Stem Cell Maintenance and a Noncanonical Polycomb Repressive Complex 1 (PRC1) Integrity.	PCGF3 PCGF5	5.71e-05	7	58	2	28049731
Pubmed	Identification of quantitative trait loci for haloperidol-induced catalepsy on mouse chromosome 14.	GLUD1 GLUD2	5.71e-05	7	58	2	10454512
Pubmed	RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis.	GLUD1 GLUD2	5.71e-05	7	58	2	19498109
Pubmed	PCGF3/5-PRC1 initiates Polycomb recruitment in X chromosome inactivation.	PCGF3 PCGF5	5.71e-05	7	58	2	28596365
Pubmed	SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.	SUPT6H ZC3H13 SMARCA1 CPSF1 BAZ1B	6.31e-05	251	58	5	31076518
GeneFamily	Ring finger proteins\|Polycomb group ring fingers	PCGF3 PCGF5	9.95e-05	7	40	2	61
GeneFamily	PDZ domain containing	MYO18A DLG3 CARD11 RIMS2	3.47e-04	152	40	4	1220
GeneFamily	Calcium voltage-gated channel subunits\|Membrane associated guanylate kinases	DLG3 CARD11	1.50e-03	26	40	2	904
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	SMARCA1 MYB	6.12e-03	53	40	2	532
GeneFamily	X-linked mental retardation\|Angiotensin receptors	USP9X DLG3	6.12e-03	53	40	2	103
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	WBP11 DLG3 ITPR1	7.43e-03	181	40	3	694
GeneFamily	Sterile alpha motif domain containing	CASKIN1 SAMD3	1.62e-02	88	40	2	760
GeneFamily	Ankyrin repeat domain containing	CASKIN1 ANKRD49 ANKRD55	1.63e-02	242	40	3	403
GeneFamily	SH2 domain containing	SH2B3 SUPT6H	2.10e-02	101	40	2	741
GeneFamily	Ring finger proteins	RNF181 PCGF3 PCGF5	2.27e-02	275	40	3	58
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	SH2B3 CDK13 USP9X VPS13C HECTD4 ANKRD49 AUTS2 BAZ1B CARD11 SAMD3 ASCC3 YTHDC1 INO80D PCGF5 JMJD1C ITPR1	9.21e-08	1492	58	16	M40023
Coexpression	GSE32255_WT_UNSTIM_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_UP	CRIM1 SH2B3 PCGF5 USP6NL ITPR1	4.31e-05	175	58	5	M8908
Coexpression	HADDAD_B_LYMPHOCYTE_PROGENITOR	P4HA2 CRIM1 CDK13 AUTS2 JMJD1C ITPR1	4.35e-05	290	58	6	M939
Coexpression	GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_6H_DN	WBP11 USP9X RNF181 RELA PCGF3	7.56e-05	197	58	5	M6107
Coexpression	GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP	CRIM1 SH2B3 SPC25 AUTS2 DLG3	7.74e-05	198	58	5	M6522
Coexpression	GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_UP	CRIM1 USP9X PCGF5 JMJD1C ITPR1	7.93e-05	199	58	5	M5607
Coexpression	GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN	CDK13 ANKRD49 AUTS2 WDR59 NGDN	8.12e-05	200	58	5	M8032
Coexpression	GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_DN	CRIM1 USP9X RNF181 YTHDC1 MYB	8.12e-05	200	58	5	M9049
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	MGAT5 CRIM1 CDK13 USP9X SPC25 SMARCA1 BAZ1B ASCC3 ITPR1	1.03e-04	856	58	9	M4500
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MGAT5 CDK13 VPS13C JMJD1C USP6NL ITPR1	2.00e-07	194	58	6	ff661419b697aef51a53fdeac8d37d870d65f491
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	USP9X VPS13C INO80D JMJD1C ITPR1	4.62e-06	188	58	5	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MGAT5 AUTS2 JMJD1C USP6NL ITPR1	4.75e-06	189	58	5	b13f315f617840eb5143a4e8a33a657c20365c21
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pro_B_progenitor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	P4HA2 CDK13 AUTS2 MYB ITPR1	4.99e-06	191	58	5	40813c397f533c2f4a6359a77757f736b6d9e07d
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate\|6m / Sample Type, Dataset, Time_group, and Cell type.	WBP11 ZC3H13 YTHDC1 JMJD1C CDH15	6.25e-06	200	58	5	7c261e39ac30b318511373ab7302aa53b8b81b9c
ToppCell	Mild/Remission-B_naive-4\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	MGAT5 SATB1 SPAG17 ITPR1	4.15e-05	148	58	4	dd5e1bc02824e743e1c030a303e32f27a359a8ca
ToppCell	Severe-B_naive-1\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	MGAT5 SATB1 PRAG1 ITPR1	5.49e-05	159	58	4	2881b054bbeb479221ee3c38bbd9b0815b123579
ToppCell	facs-Lung-ENDOMUCIN-18m-Lymphocytic-Natural_Killer\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAT5 CARD11 SAMD3 PRAG1	5.91e-05	162	58	4	0321fc954ae4ad67ca438cbbc84632562d222188
ToppCell	facs-Lung-ENDOMUCIN-18m-Lymphocytic-NK_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAT5 CARD11 SAMD3 PRAG1	5.91e-05	162	58	4	5731f9514434296132df4bc86f78ce87b07cdeca
ToppCell	Mild/Remission-B_naive-4\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	MGAT5 SATB1 SPAG17 ITPR1	6.96e-05	169	58	4	c3a6179a64589a370108fea809b157839347759c
ToppCell	COVID-19-B_cells-Activated_B_cells\|COVID-19 / group, cell type (main and fine annotations)	MGAT5 CARD11 USP6NL ITPR1	8.32e-05	177	58	4	653bb62a3744d4024ab3186ee01d410ed62832a6
ToppCell	nucseq-Immune-Lymphocytic_B-Lymphocytic_B-B\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MGAT5 CARD11 USP6NL ITPR1	9.07e-05	181	58	4	8d8cc4dae2c8bd5f4b1c159f2a52edc4c9449c86
ToppCell	IPF-Lymphoid-B\|IPF / Disease state, Lineage and Cell class	MGAT5 AUTS2 CARD11 ITPR1	9.47e-05	183	58	4	e37d2c015c34471a8a54a0299e94b0371e1ada5a
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VPS13C BAZ1B ASCC3 JMJD1C	9.67e-05	184	58	4	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	human_hepatoblastoma-Hepatic_Stellate_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	OLFML2B GLI3 NEXN ITPR1	1.01e-04	186	58	4	cb1fc4b9140666b43415e21c9b434dc9b144e9d0
ToppCell	E16.5-samps-Mesenchymal-Myofibroblast\|E16.5-samps / Age Group, Lineage, Cell class and subclass	SUPT6H OLFML2B PRAG1 NEXN	1.01e-04	186	58	4	e044b3428b7eacfdc72d0f57cdabaa1de04c74cd
ToppCell	droplet-Tongue-nan-24m-Epithelial-parabasal\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DSC1 PDZK1IP1 MYO18A USP6NL	1.01e-04	186	58	4	18c06041c6c8a0ebac17b3c8aaebd67e652d315a
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NRTN OLFML2B AUTS2 NEXN	1.03e-04	187	58	4	218c9b4f28499389c43005d9626af2ac01066027
ToppCell	human_hepatoblastoma-Tumor_cells-T2\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ACACB ZC3H13 GLUD1 WDR59	1.03e-04	187	58	4	f3e37c18ac6471c7992609bbddfa4975571c815c
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NRTN OLFML2B AUTS2 NEXN	1.03e-04	187	58	4	c7ac4b328efc2ebb72f71154661914193ff402ca
ToppCell	renal_medulla_nuclei-Adult_normal_reference\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	MGAT5 ACACB AUTS2 JMJD1C	1.09e-04	190	58	4	f1363f7806cfc4f14fbc1b0e8dac2de813a88eee
ToppCell	10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD4_rest-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ZC3H13 SAMD3 ASCC3 WDR59	1.09e-04	190	58	4	69c5c4d5f4fb6e5ae2c9dbf9d209faf093c3f769
ToppCell	facs-Pancreas-Endocrine-3m\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USP9X SMARCA1 RIMS2 ITPR1	1.12e-04	191	58	4	b3de0393d6510543533cd851e47a0f95739a0e4e
ToppCell	facs-Pancreas-Endocrine-3m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USP9X SMARCA1 RIMS2 ITPR1	1.12e-04	191	58	4	657297cd19d05a7e7bb74fc3a086fbd95f47aae4
ToppCell	droplet-Fat-Gat-18m-Endothelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACACB CRIM1 HSPA12B PRAG1	1.14e-04	192	58	4	c312e39003c51503c9f648332fb5c6218f33f99b
ToppCell	droplet-Fat-Gat-18m-Endothelial-Cd36+\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACACB CRIM1 HSPA12B PRAG1	1.14e-04	192	58	4	df09056f0e562f53b6fb30b674d2d83e9eb857d0
ToppCell	RA-09._Endothelium_I\|RA / Chamber and Cluster_Paper	CRIM1 SPC25 HSPA12B PRAG1	1.14e-04	192	58	4	8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc
ToppCell	droplet-Fat-Gat-18m-Endothelial-endothelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACACB CRIM1 HSPA12B PRAG1	1.14e-04	192	58	4	133b3ad251d72ff31e45e1dc6217945516ac63de
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	SH2B3 POLR1C PCGF3 ITPR1	1.16e-04	193	58	4	08696a99309f5b088692ddac8cca35413b5e810d
ToppCell	Control-CD8+_T_naive\|Control / Disease condition and Cell class	DSC1 SATB1 PRAG1 MYB	1.16e-04	193	58	4	627d345baf1940218c61907305705298e473dbab
ToppCell	facs-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SATB1 VPS13C HECTD4 MYB	1.16e-04	193	58	4	a6a864644e1b80b7417ea0a27281e79068a3fd3d
ToppCell	facs-Diaphragm-Limb_Muscle-3m-Mesenchymal\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OLFML2B RELA JMJD1C CDH15	1.21e-04	195	58	4	4d63e0dca30ae57960459d2fbcba09122273e37b
ToppCell	10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	P4HA2 CDK13 JMJD1C ITPR1	1.21e-04	195	58	4	dc84a910b6f6eb9994cd683aa4fd813a82198e5f
ToppCell	facs-Diaphragm-Limb_Muscle-3m-Mesenchymal-nan\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OLFML2B RELA JMJD1C CDH15	1.21e-04	195	58	4	661af601a3561fe3aacf2444ad7b8927fa88b48a
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SATB1 USP9X VPS13C ASCC3	1.21e-04	195	58	4	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SATB1 USP9X VPS13C ASCC3	1.21e-04	195	58	4	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VPS13C ASCC3 NEXN JMJD1C	1.21e-04	195	58	4	5c86fddd6d0530beecf45ea5ba6b823123847696
ToppCell	background-Endothelial_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	CRIM1 AUTS2 PRAG1 ANKRD55	1.23e-04	196	58	4	e6fb0bfab1779ec64a8c35d01519eaafbf62e977
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OLFML2B USP9X GLUD1 JMJD1C	1.23e-04	196	58	4	151f1a29a91f8b234e9b6ed062666357a2f69128
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OLFML2B USP9X RELA CDH15	1.26e-04	197	58	4	5bc11aff92da2a0aca8473f997fe7a99f3cae75d
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	OLFML2B GLI3 SMARCA1 CDH15	1.26e-04	197	58	4	c165c6fd12dc649b39e920d8528e2eb65c61956b
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	ZC3H13 YTHDC1 RIMS2 NEXN	1.26e-04	197	58	4	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	Control-Control-Lymphocyte-T/NK-NK_activated\|Control / Disease, condition lineage and cell class	MGAT5 SUPT6H DLG3 CARD11	1.28e-04	198	58	4	76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	CRIM1 VPS13C ZC3H13 INO80D	1.31e-04	199	58	4	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	control-unassigned\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SATB1 ACACB SMARCA1 ANKRD55	1.31e-04	199	58	4	50e2da35edff1aadef939cfbd4549f73c1a07717
ToppCell	control-unassigned\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SATB1 ACACB SMARCA1 ANKRD55	1.31e-04	199	58	4	5db7c8089172ac8e796613b3cef618d87007a0ab
ToppCell	Macroglial-Astrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ACACB GLI3 GLUD1 DNAH7	1.33e-04	200	58	4	941536b7c32f1e63c70535233b2ccce0cd7bf96e
ToppCell	Macroglial-Astrocytes-SLC14A1---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ACACB GLI3 GLUD1 DNAH7	1.33e-04	200	58	4	d6fcbf4f4bc1b89a9929d7b114c6b907b6979900
ToppCell	Macroglial-Astrocytes-SLC14A1----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ACACB GLI3 GLUD1 DNAH7	1.33e-04	200	58	4	f861509b54185d89931db64da1b9d81986cc7938
ToppCell	Sepsis-Int-URO-Lymphocyte-T/NK-dn_T\|Int-URO / Disease, condition lineage and cell class	CPSF1 SAMD3 USP6NL MYB	1.33e-04	200	58	4	020439d9e70fff7246650ab0e9105236688c3ec3
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CDK13 VPS13C YTHDC1 JMJD1C	1.33e-04	200	58	4	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Macroglial-Astrocytes-SLC14A1\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ACACB GLI3 GLUD1 DNAH7	1.33e-04	200	58	4	16f468217427921fa18c6d078ffa990eb019b257
ToppCell	Influenza-Influenza_Severe-Lymphocyte-T/NK-CD4+_T_naive\|Influenza_Severe / Disease, condition lineage and cell class	DSC1 NRTN ANKRD55 MYB	1.33e-04	200	58	4	0382f8fc27d18003761725e714beb6b3f3150057
ToppCell	Macroglial-Astrocytes-SLC14A1--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ACACB GLI3 GLUD1 DNAH7	1.33e-04	200	58	4	0442894c39eec69850c090957a5dc7bcecd21e04
ToppCell	Macroglial-Astrocytes-SLC14A1-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ACACB GLI3 GLUD1 DNAH7	1.33e-04	200	58	4	01819446deeab9054f5cfe889d53bb49d137dbc0
ToppCell	severe-CD4+_T_naive\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SATB1 ANKRD55 PCGF5 MYB	1.33e-04	200	58	4	f74bdabadca8ad6dae1b6e6812c66325aac50db0
Drug	phenyltriethoxysilane	GLUD1 GLUD2	6.38e-06	2	58	2	CID000013075
Drug	methylmercuric bromide	GLUD1 GLUD2	6.38e-06	2	58	2	CID000068175
Drug	5-methylisophthalate	GLUD1 GLUD2	6.38e-06	2	58	2	CID000068137
Drug	G-3SH	GLUD1 GLUD2	6.38e-06	2	58	2	CID000174237
Drug	x 1 s	GLUD1 GLUD2	6.38e-06	2	58	2	CID000409694
Drug	iodoacetyldiethylstilbestrol	GLUD1 GLUD2	6.38e-06	2	58	2	CID006455327
Drug	Ricinine [524-40-3]; Down 200; 24.4uM; HL60; HT_HG-U133A	CDK13 RELA PCGF3 ANKRD55 INO80D NGDN	9.63e-06	193	58	6	2505_DN
Drug	phenanthridinone; Up 200; 51.2uM; MCF7; HT_HG-U133A_EA	SUPT6H VPS13C BAZ1B DLG3 RELA PCGF3	9.63e-06	193	58	6	1115_UP
Drug	AG-013608 [351320-38-2]; Up 200; 10uM; MCF7; HT_HG-U133A	DSC1 SATB1 SMARCA1 AUTS2 ITPR1 NGDN	1.05e-05	196	58	6	6435_UP
Drug	Ethambutol dihydrochloride [1070-11-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A	IRS4 ACACB CDK13 OLFML2B RIMS2 MYB	1.08e-05	197	58	6	4120_UP
Drug	5-amino-1-phenyltetrazole	GLUD1 GLUD2 MYB	1.73e-05	20	58	3	CID000021640
Drug	methoxyethylmercury	GLUD1 GLUD2	1.91e-05	3	58	2	CID000115155
Drug	4-methylumbelliferyl laurate	GLUD1 GLUD2	1.91e-05	3	58	2	CID000600674
Drug	methylmercuric iodide	GLUD1 GLUD2	1.91e-05	3	58	2	CID000067347
Drug	lenthionine	GLUD1 GLUD2	1.91e-05	3	58	2	CID000067521
Drug	mildiomycin	GLUD1 GLUD2	1.91e-05	3	58	2	CID000125665
Drug	methyl benzoquate	GLUD1 GLUD2	3.81e-05	4	58	2	CID000026383
Drug	8-BDB-TADP	GLUD1 GLUD2	3.81e-05	4	58	2	CID000130791
Drug	cadina-3,9-diene	GLUD1 GLUD2	3.81e-05	4	58	2	CID000010657
Drug	AC1L9CUQ	GLUD1 GLUD2	3.81e-05	4	58	2	CID000442451
Drug	pentenoic acid	GLUD1 GLUD2	3.81e-05	4	58	2	CID000012299
Drug	alpha-ketoglutaramate	GLUD1 GLUD2	3.81e-05	4	58	2	CID000000048
Drug	luxabendazole	GLUD1 GLUD2	3.81e-05	4	58	2	CID000072019
Drug	ureidoglycine	GLUD1 GLUD2	3.81e-05	4	58	2	CID000439649
Drug	N-butylmaleimide	GLUD1 GLUD2	3.81e-05	4	58	2	CID000239780
Drug	Ivin	GLUD1 GLUD2	3.81e-05	4	58	2	CID000014083
Drug	alpha-methylglutamate	GLUD1 GLUD2	3.81e-05	4	58	2	CID000095440
Drug	2b E2	GLUD1 GLUD2	3.81e-05	4	58	2	CID005327076
Drug	isophthalate	GLI3 GLUD1 GLUD2	3.91e-05	26	58	3	CID000008496
Drug	1-pheg	GLUD1 GLUD2	6.35e-05	5	58	2	CID000152041
Drug	5'-FSBAzA	GLUD1 GLUD2	6.35e-05	5	58	2	CID000130430
Drug	adenine N1-oxide	GLUD1 GLUD2	6.35e-05	5	58	2	CID000093557
Drug	bathocuproine	GLUD1 GLUD2	6.35e-05	5	58	2	CID000065149
Drug	choline sulfate	GLUD1 GLUD2	6.35e-05	5	58	2	CID000000485
Drug	l-413	GLUD1 GLUD2	6.35e-05	5	58	2	CID000012475
Drug	AC1NRA4I	GLUD1 GLUD2	6.35e-05	5	58	2	CID005287695
Drug	isosteviol lactone	GLUD1 GLUD2	6.35e-05	5	58	2	CID000401559
Drug	3-aminopicolinate	GLUD1 GLUD2	6.35e-05	5	58	2	CID000073836
Drug	thioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A	ACACB OLFML2B RIMS2 MYB ITPR1	9.29e-05	179	58	5	5590_UP
Drug	alpha-monofluoromethylputrescine	GLUD1 GLUD2	9.50e-05	6	58	2	CID000134201
Drug	dadAB	GLUD1 GLUD2	9.50e-05	6	58	2	CID000022626
Drug	N-methylhydantoin	GLUD1 GLUD2	9.50e-05	6	58	2	CID000069217
Drug	diazonium-1-H-tetrazole	GLUD1 GLUD2	9.50e-05	6	58	2	CID000188312
Drug	AC1L448Y	GLUD1 GLUD2	9.50e-05	6	58	2	CID000200389
Drug	2-BDB-TAMP	GLUD1 GLUD2	9.50e-05	6	58	2	CID000127220
Drug	Emid	GLUD1 GLUD2	9.50e-05	6	58	2	CID000074798
Drug	dimethylmalonate	GLUD1 GLUD2	9.50e-05	6	58	2	CID000007943
Drug	AC1L8SA5	GLUD1 GLUD2	9.50e-05	6	58	2	CID000407285
Drug	2-methyl-1,2,3,4-tetrahydroisoquinoline	GLUD1 GLUD2	9.50e-05	6	58	2	CID000015362
Drug	lanosol	GLUD1 GLUD2	9.50e-05	6	58	2	CID000078659
Drug	isodiazinon	GLUD1 GLUD2	9.50e-05	6	58	2	CID000133913
Drug	Betulinic acid [472-15-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A	SH2B3 BAZ1B RELA WDR59 ITPR1	1.17e-04	188	58	5	3281_UP
Drug	carbophenothion	GLUD1 GLUD2	1.33e-04	7	58	2	CID000013081
Drug	37474A	GLUD1 GLUD2	1.33e-04	7	58	2	CID004330138
Drug	AC1L1B5W	GLUD1 GLUD2	1.33e-04	7	58	2	CID000001296
Drug	2-oxoglutaconic acid	GLUD1 GLUD2	1.33e-04	7	58	2	CID006443759
Drug	d-serine methyl ester hydrochloride	GLUD1 GLUD2	1.33e-04	7	58	2	CID000090387
Drug	PHA-00745360 [351320-33-7]; Down 200; 1uM; MCF7; HT_HG-U133A	CDK13 CPSF1 RIMS2 ITPR1 NGDN	1.36e-04	194	58	5	3910_DN
Drug	semustine; Down 200; 100uM; PC3; HT_HG-U133A	ACACB GLI3 DLG3 MYB ITPR1	1.36e-04	194	58	5	7545_DN
Drug	Tiapride hydrochloride [51012-33-0]; Up 200; 11uM; MCF7; HT_HG-U133A	CDK13 VPS13C ZC3H13 ITPR1 NGDN	1.39e-04	195	58	5	4686_UP
Drug	Propidium iodide [25535-16-4]; Up 200; 6uM; MCF7; HT_HG-U133A	CPSF1 DNAH7 CDH15 ITPR1 NGDN	1.39e-04	195	58	5	6104_UP
Drug	diclofenac sodium; Up 200; 10uM; PC3; HG-U133A	ACACB ZC3H13 CPSF1 RIMS2 CDH15	1.39e-04	195	58	5	445_UP
Drug	Oxymetazoline hydrochloride [2315-02-8]; Down 200; 13.4uM; MCF7; HT_HG-U133A	BAZ1B DLG3 RIMS2 WDR59 NGDN	1.39e-04	195	58	5	2278_DN
Drug	Esculin Hydrate [531-75-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A	CRIM1 CDK13 SUPT6H PCGF3 INO80D	1.42e-04	196	58	5	5411_DN
Drug	Nialamide [51-12-7]; Up 200; 13.4uM; MCF7; HT_HG-U133A	MGAT5 ACACB OLFML2B ZC3H13 ITPR1	1.42e-04	196	58	5	4347_UP
Drug	AH6809; Up 200; 1uM; PC3; HT_HG-U133A	NRTN OLFML2B BAZ1B PCGF3 INO80D	1.46e-04	197	58	5	7049_UP
Drug	Conessine [546-06-5]; Up 200; 11.2uM; MCF7; HT_HG-U133A	CDK13 SMARCA1 WDR59 ITPR1 NGDN	1.46e-04	197	58	5	2792_UP
Drug	2-Aminobenzenesulfonamide [3306-62-5]; Up 200; 23.2uM; MCF7; HT_HG-U133A	SATB1 WDR59 USP6NL MYB ITPR1	1.49e-04	198	58	5	5422_UP
Drug	Naringin hydrate [11032-30-7]; Up 200; 6.6uM; MCF7; HT_HG-U133A	ACACB SUPT6H RIMS2 ITPR1 NGDN	1.49e-04	198	58	5	3286_UP
Drug	Ondansetron Hydrochloride [103639-04-9]; Up 200; 12.2uM; MCF7; HT_HG-U133A	BAZ1B DNAH7 INO80D WDR59 NGDN	1.49e-04	198	58	5	6270_UP
Drug	Nizatidine [76963-41-2]; Up 200; 12uM; MCF7; HT_HG-U133A	SMARCA1 AUTS2 WDR59 MYB ITPR1	1.49e-04	198	58	5	5406_UP
Drug	Racecadotril [81110-73-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A	GLI3 BAZ1B RELA PCGF3 WDR59	1.49e-04	198	58	5	2774_DN
Drug	Xylazine [7361-61-7]; Up 200; 18.2uM; MCF7; HT_HG-U133A	IRS4 ACACB CDK13 OLFML2B DNAH7	1.49e-04	198	58	5	4147_UP
Drug	Sulfachloropyridazine [80-32-0]; Up 200; 14uM; MCF7; HT_HG-U133A	DSC1 SATB1 SMARCA1 DNAH7 NGDN	1.53e-04	199	58	5	3944_UP
Drug	Bemegride [64-65-3]; Up 200; 25.8uM; MCF7; HT_HG-U133A	DSC1 ACACB NRTN USP6NL ITPR1	1.53e-04	199	58	5	3389_UP
Drug	Cephalosporanic acid, 7-amino [957-68-6]; Up 200; 14.6uM; MCF7; HT_HG-U133A	CDK13 ZC3H13 BAZ1B RIMS2 ITPR1	1.53e-04	199	58	5	4826_UP
Drug	Cefalonium [5575-21-3]; Up 200; 8.8uM; HL60; HT_HG-U133A	IRS4 MGAT5 ACACB DLG3 RIMS2	1.53e-04	199	58	5	2921_UP
Drug	6-chloroquinoxaline-2,3-diol	GLUD1 GLUD2	1.77e-04	8	58	2	CID000081143
Drug	2-heptanol	GLUD1 GLUD2	1.77e-04	8	58	2	CID000010976
Drug	2'(3')-O-(2,4,6-trinitrophenyl)-ADP	GLUD1 GLUD2	1.77e-04	8	58	2	CID000644359
Drug	Nessler's reagent	GLUD1 GLUD2	1.77e-04	8	58	2	CID000024542
Drug	iminoglutarate	GLUD1 GLUD2	1.77e-04	8	58	2	CID000152649
Drug	bidisomide	GLUD1 GLUD2	1.77e-04	8	58	2	CID000059798
Drug	Pheg	GLUD1 GLUD2	1.77e-04	8	58	2	CID003080746
Drug	AC1MQ2IK	GLUD1 GLUD2	1.77e-04	8	58	2	CID003394958
Drug	AC1N690Y	GLUD1 GLUD2	1.77e-04	8	58	2	CID004256264
Drug	trimethyllead chloride	GLUD1 GLUD2	1.77e-04	8	58	2	CID000223969
Drug	NHS-ASA	GLUD1 GLUD2	2.27e-04	9	58	2	CID003035647
Drug	dimethyl L-glutamate	GLUD1 GLUD2	2.27e-04	9	58	2	CID000093032
Drug	AC1L1GWH	GLUD1 GLUD2	2.27e-04	9	58	2	CID000003872
Drug	AC1N4HBY	GLUD1 GLUD2	2.27e-04	9	58	2	CID004128835
Drug	DCQX	GLUD1 GLUD2	2.27e-04	9	58	2	CID000001845
Drug	adipamide	GLUD1 GLUD2	2.27e-04	9	58	2	CID000012364
Drug	temelastine	GLUD1 GLUD2	2.27e-04	9	58	2	CID000055482
Drug	Asparagusate	GLUD1 GLUD2	2.27e-04	9	58	2	CID000016682
Drug	silver nitrate	GLUD1 GLUD2 SPAG17	2.66e-04	49	58	3	CID000024470
Drug	bis-NAD	GLUD1 GLUD2	2.83e-04	10	58	2	CID003081557
Drug	NmiQ	GLUD1 GLUD2	2.83e-04	10	58	2	CID000019850
Drug	S884	GLUD1 GLUD2	2.83e-04	10	58	2	CID004685067
Drug	diglycerol	GLUD1 GLUD2	2.83e-04	10	58	2	CID000042953
Disease	fascioliasis (biomarker_via_orthology)	GLUD1 GLUD2	1.06e-05	3	56	2	DOID:885 (biomarker_via_orthology)
Disease	childhood absence epilepsy (biomarker_via_orthology)	GLUD1 GLUD2	5.28e-05	6	56	2	DOID:1825 (biomarker_via_orthology)
Disease	neutrophil count, eosinophil count	SH2B3 SPC25 HECTD4 PCGF3 JMJD1C	5.30e-05	213	56	5	EFO_0004833, EFO_0004842
Disease	neutrophil count, basophil count	SH2B3 SPC25 HECTD4 PCGF3 JMJD1C	6.72e-05	224	56	5	EFO_0004833, EFO_0005090
Disease	vascular cell adhesion protein 1 measurement	MGAT5 SH2B3	7.38e-05	7	56	2	EFO_0020846
Disease	alkaline phosphatase measurement	MGAT5 ACACB NRTN GLI3 CASKIN1 BAZ1B PRAG1 JMJD1C ITPR1	1.15e-04	1015	56	9	EFO_0004533
Disease	granulocyte count	SH2B3 SPC25 HECTD4 PCGF3 JMJD1C	1.21e-04	254	56	5	EFO_0007987
Disease	multiple sclerosis	MGAT5 SH2B3 CARD11 ANKRD55 CDH15 MYB ITPR1	1.28e-04	594	56	7	MONDO_0005301
Disease	Ischemic stroke, fibrinogen measurement	SH2B3 HECTD4 JMJD1C	1.58e-04	55	56	3	EFO_0004623, HP_0002140
Disease	fibrinogen measurement, factor VII measurement	SH2B3 HECTD4 JMJD1C	1.86e-04	58	56	3	EFO_0004619, EFO_0004623
Disease	forced expiratory volume, body mass index	SH2B3 HECTD4	1.92e-04	11	56	2	EFO_0004314, EFO_0004340
Disease	total blood protein measurement	CRIM1 SH2B3 SPC25 ASCC3 HSPA12B ANKRD55	2.05e-04	449	56	6	EFO_0004536
Disease	venous thromboembolism, fibrinogen measurement	SH2B3 HECTD4 JMJD1C	2.85e-04	67	56	3	EFO_0004286, EFO_0004623
Disease	C-X-C motif chemokine 11 measurement	SH2B3 JMJD1C	3.17e-04	14	56	2	EFO_0008057
Disease	hepatic encephalopathy (biomarker_via_orthology)	GLUD1 GLUD2	3.66e-04	15	56	2	DOID:13413 (biomarker_via_orthology)
Disease	Ischemic stroke, tissue plasminogen activator measurement	SH2B3 HECTD4	3.66e-04	15	56	2	EFO_0004791, HP_0002140
Disease	lymphocyte count	P4HA2 SH2B3 CDK13 SPC25 HECTD4 AUTS2 CARD11 JMJD1C MYB ITPR1	3.87e-04	1464	56	10	EFO_0004587
Disease	mitochondrial DNA measurement	NRTN SPC25 PCGF3 JMJD1C MYB	3.95e-04	328	56	5	EFO_0006312
Disease	Ischemic stroke, plasminogen activator inhibitor 1 measurement	SH2B3 HECTD4	4.17e-04	16	56	2	EFO_0004792, HP_0002140
Disease	myopia (is_implicated_in)	P4HA2 CPSF1	4.17e-04	16	56	2	DOID:11830 (is_implicated_in)
Disease	factor XI measurement, Ischemic stroke	SH2B3 HECTD4	4.72e-04	17	56	2	EFO_0004694, HP_0002140
Disease	metabolic syndrome	SPC25 HECTD4 BAZ1B JMJD1C	5.71e-04	200	56	4	EFO_0000195
Disease	factor VIII measurement, Ischemic stroke	SH2B3 HECTD4	5.93e-04	19	56	2	EFO_0004630, HP_0002140
Disease	platelet-to-lymphocyte ratio	SH2B3 SPC25 AUTS2 JMJD1C MYB	6.26e-04	363	56	5	EFO_0008446
Disease	neuroticism measurement, cognitive function measurement	SH2B3 AUTS2 ASCC3 PCGF3 PCGF5 JMJD1C	6.99e-04	566	56	6	EFO_0007660, EFO_0008354
Disease	transferrin glycosylation measurement	MGAT5 NRTN	7.26e-04	21	56	2	EFO_0021537
Disease	N-glycan measurement	MGAT5 NRTN	7.98e-04	22	56	2	EFO_0004999
Disease	mean arterial pressure, alcohol drinking	SH2B3 GLI3 HECTD4	8.67e-04	98	56	3	EFO_0004329, EFO_0006340
Disease	myeloproliferative disorder	SH2B3 MYB	1.03e-03	25	56	2	EFO_0004251
Disease	fibrinogen measurement	SH2B3 JMJD1C ITPR1	1.18e-03	109	56	3	EFO_0004623
Disease	Ischemic stroke, factor VII measurement	SH2B3 HECTD4	1.39e-03	29	56	2	EFO_0004619, HP_0002140
Disease	Drugs used in diabetes use measurement	SPC25 AUTS2 DNAH7 JMJD1C	1.41e-03	255	56	4	EFO_0009924
Disease	fatty acid measurement	MGAT5 ACACB BAZ1B PRAG1 JMJD1C	1.42e-03	436	56	5	EFO_0005110
Disease	diastolic blood pressure, unipolar depression	SH2B3 HECTD4	1.49e-03	30	56	2	EFO_0003761, EFO_0006336
Disease	Ischemic stroke, von Willebrand factor measurement	SH2B3 HECTD4	1.49e-03	30	56	2	EFO_0004629, HP_0002140
Disease	aspartate aminotransferase measurement	P4HA2 MGAT5 SH2B3 SPC25 HECTD4 PRAG1 ITPR1	1.55e-03	904	56	7	EFO_0004736
Disease	serum IgA measurement	SH2B3 ANKRD55	1.59e-03	31	56	2	EFO_0004912
Disease	temporal lobe epilepsy (biomarker_via_orthology)	GLUD1 GLUD2	1.59e-03	31	56	2	DOID:3328 (biomarker_via_orthology)
Disease	fatty liver disease (implicated_via_orthology)	ACACB RELA	1.59e-03	31	56	2	DOID:9452 (implicated_via_orthology)
Disease	inflammatory bowel disease	P4HA2 SH2B3 ZC3H13 RELA ANKRD55	1.61e-03	449	56	5	EFO_0003767
Disease	serum gamma-glutamyl transferase measurement	RNF181 HECTD4 BAZ1B HSPA12B JMJD1C USP6NL ITPR1	1.65e-03	914	56	7	EFO_0004532
Disease	Mental Retardation, X-Linked 1	USP9X DLG3	1.69e-03	32	56	2	C2931498
Disease	coffee consumption	HECTD4 BAZ1B	1.69e-03	32	56	2	EFO_0004330
Disease	eosinophil count	MGAT5 SH2B3 SPC25 HECTD4 CARD11 RELA DNAH7 WDR59 MYB	1.83e-03	1488	56	9	EFO_0004842

Protein segments in the cluster

Peptide	Gene	Start	Entry
PHTQEAFRTREEYEA	BAZ1B	26	Q9UIG0
HQKDPSRDRYREEDT	ANKRD55	361	Q3KP44
TEEDLDYRTENQHVP	CDK13	1271	Q14004
KPEEDNDYHRSDEQV	PCGF3	141	Q3KNV8
AENFHEEDDVDVRPA	NEXN	486	Q0ZGT2
FQEDHYPDSDKRREI	NOBOX	291	O60393
RPTAYEDEVSFLDAH	NRTN	166	Q99748
DEFAEDRIYRHLEPA	ACACB	1481	O00763
HSLNRYAASDSEPER	CASKIN1	881	Q8WXD9
NEDDKDYHRSDPQIA	PCGF5	126	Q86SE9
NEDESPGQTYHRERR	GLI3	41	P10071
PSHYEEALRDEEERA	MAGEB1	301	P43366
PYEEADHNSLAEIRT	MGAT5	206	Q09328
TTFRREADPDDHYQP	ITPR1	1936	Q14643
SHRDSRNPDLAVYVE	JMJD1C	46	Q15652
ERDERYIHPQQEAFS	CPSF1	1061	Q10570
DDEHDPLDNTSRPRY	MYO18A	2021	Q92614
RSSEHENAYENVPEE	PDZK1IP1	91	Q13113
EADRSFRDREPHDYS	AUTS2	1111	Q8WXX7
AAAAIQRHYNDEDPE	MYB	276	P10242
VNTRDEDEYTPLHRA	ANKRD49	101	Q8WVL7
RFGSDEDDHYRLNDE	HECTD4	391	Q9Y4D8
TARDYYHDLDPEEAR	HSPA12B	121	Q96MM6
QYEPHFDFSRNDERD	P4HA2	426	O15460
DRRSQHEPQFYEDSD	RIMS2	306	Q9UQ26
DRDCEAADRQPYHRS	RIMS2	1076	Q9UQ26
RHYSEAVADREDDPN	GLUD1	51	P00367
CDFHDPKREDTNYRE	DNAH7	2271	Q8WXX0
QVDYRDNRLHPSEDS	CRIM1	921	Q9NZV1
RPRRDNEVDGQDYHF	DLG3	661	Q92796
KIEDDNDNAPYFEHR	DSC1	231	Q08554
TLRYQRHASDDDDAE	INO80D	351	Q53TQ3
EEDQDAYDISQLRHP	CDH15	661	P55291
RYKEDAPHRSTVEED	CARD11	576	Q9BXL7
RHYSELVADREDDPN	GLUD2	51	P49448
PHRARAFDEDEDDPY	IRS4	686	O14654
ARDHEDYDPQTVRLG	USP9X	631	Q93008
AGDYRHRRTEQEEDE	SMARCA1	141	P28370
PTDDDTYEEHRRDKA	RNF181	121	Q9P0P0
YRDEESSSPARHGEQ	SAMD3	91	Q8N6K7
HADPRLFEYRNQGDE	POLR1C	116	O15160
DLPEDRYDKAQATAH	TEX45	256	Q8NA69
RDAAAAYAHPEYEER	OLFML2B	231	Q68BL8
PERDAIYEQESNAVH	SATB1	561	Q01826
RGEDDHTNRYIDDEP	SPAG17	201	Q6Q759
HTNRYIDDEPDDGAQ	SPAG17	206	Q6Q759
LNEARDYEVSDSAPH	SPC25	176	Q9HBM1
DAEEYTDLPVRHNED	ASCC3	1851	Q8N3C0
RDSYQRHETEQFPAE	SUPT6H	551	Q7KZ85
EEALERAYSQSPRHA	USP6NL	566	Q92738
EQYSDAPEEIRDARH	NGDN	211	Q8NEJ9
PDHGDRSFYDLEADQ	PRAMEF11	461	O60813
HLEHEPVNRARDSDY	SH2B3	541	Q9UQQ2
HEDGIIRPYDRQESE	VPS13C	3601	Q709C8
SAHEPENPEDTYERR	REM2	141	Q8IYK8
DSAASHQAEPEAYER	PRAG1	1106	Q86YV5
DVGRRRPEDYDIHNS	YTHDC1	531	Q96MU7
LTYSDPRERERDQHD	WDR59	831	Q6PJI9
YSPELAQRGHDDDVS	WBP11	236	Q9Y2W2
FQYLPDTDDRHRIEE	RELA	286	Q04206
RREHSPDSDAYNSGD	ZC3H13	841	Q5T200